https://slatemedicines.com/ 2026-10-20T15:07:07+00:00 https://slatemedicines.com/news/slate-medicines-launches-with-130-million-series-a-financing-to-advance-anti-pacap-therapies-for-the-prevention-of-migraine-and-other-headache-disorders/ 2026-04-27T18:03:14+00:00 https://slatemedicines.com/news/slate-medicines-appoints-john-umstead-as-chief-financial-officer/ 2026-05-22T10:15:18+00:00 https://slatemedicines.com/news/slate-medicines-strengthens-board-of-directors-with-appointment-of-mark-w-hahn/ 2026-07-15T05:00:18+00:00 https://slatemedicines.com/news/slate-medicines-establishes-clinical-and-scientific-advisory-boards-to-advance-next-generation-migraine-prevention-therapeutics/ 2026-07-27T20:48:06+00:00 https://slatemedicines.com/news/fulcrum-therapeutics-and-slate-medicines-announce-merger-agreement-to-advance-next-generation-migraine-therapies/ 2026-08-17T08:35:58+00:00 https://slatemedicines.com/news/slate-medicines-announces-first-participant-dosed-in-phase-1-study-evaluating-slte-1009/ 2026-09-11T09:28:39+00:00 https://slatemedicines.com/news/slate-medicines-appoints-kenneth-koblan-phd-as-chief-scientific-officer/ 2026-09-14T14:46:48+00:00 https://slatemedicines.com/news/slate-medicines-strengthens-board-of-directors-with-appointment-of-stephen-k-brannan-md-and-john-d-young/ 2026-10-20T02:11:01+00:00